Compare iShares Core MSCI Emerging Markets ETF (IEMG) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Core MSCI Emerging Markets ETF vs Tenet Healthcare Corporation — how do they compare? iShares Core MSCI Emerging Markets ETF trades at $80.91, while Tenet Healthcare Corporation trades at $264 (market cap $20.89B). The key difference: Tenet Healthcare Corporation is trading nearer its 52-week high, iShares Core MSCI Emerging Markets ETF nearer its low. Which is the better fit depends on your goals.
| IEMG | THC | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $86.00 | $262.63 |
52-Week Low | $61.76 | $161.37 |
Market Cap | — | $20.89B |
Enterprise Value | — | $31.97B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IEMG trades at $81.10, up 1.93% with a bullish technical signal from moving averages. The ETF shows strong momentum with 35% trailing returns but faces elevated volatility. Recent news highlights IEMG's 40% technology weighting and AI exposure in emerging markets, though some analysts caution about concentration risks after significant gains.
The outlook remains positive given attractive emerging market valuations and AI-driven growth potential, but investors should monitor volatility and geopolitical risks. The ETF's low 0.09% expense ratio and diversification across 2,700 stocks provide cost-effective exposure to developing economies with superior dividend growth prospects.
Tenet Healthcare (THC) trades at $260.67, up 0.28% today, with strong technical momentum including a golden cross pattern and bullish moving average alignment. The company demonstrates robust fundamentals with Q2 2026 EPS beating expectations at $6.12 versus $4.26 forecast, maintaining a three-quarter earnings beat streak. Valuation metrics remain attractive with P/E of 10.03 and EV/EBITDA of 5.73, while profitability metrics show exceptional ROE of 53.31% and net margin of 9.9%.
The investment outlook remains positive with 81% analyst buy ratings and $281.44 consensus price target representing 8% upside. Key risks include policy headwinds in ACA exchanges and hospital segment challenges, though strong ambulatory growth provides offset. The stock presents a compelling value-growth combination with momentum characteristics, supported by institutional accumulation and positive earnings revisions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares Core MSCI Emerging Markets ETF
IEMG tracks the MSCI Emerging Markets Investable Market Index, providing broad exposure to large, mid, and small-cap stocks across over 20 emerging market countries. It is designed as a low-cost core holding for investors seeking diversified growth from economies outside of developed markets.
Read more on IEMG →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
